Search research articles
Contact Us
Filters
Showing results (291-300 of 316) with videos related to
Page
of 32
Sort By:
Journal of Gastroenterology
|
May 4, 2011
Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, et al.
The Journal of Dermatology
|
January 25, 2023
Clinical characteristics of patients with psoriasis with family history: A multicenter observational study
Chika Ohata, Hisataka Anezaki, Sakae Kaneko, et al.
Journal of Gastroenterology
|
March 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests
Kazuhito Kawata, Hirokazu Takahashi, Taeang Arai, et al.
Journal of Gastroenterology
|
April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years
Tetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.
Journal of Gastroenterology
|
July 31, 2015
The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin
Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology
|
November 12, 2014
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection
Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology
|
October 26, 2025
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma
Kazuki Maesaka, Hayato Hikita, Yuki Tahata, et al.
Cardiovascular Diabetology
|
December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
Journal of Gastroenterology and Hepatology
|
September 9, 2025
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma
Kazuki Maesaka, Hayato Hikita, Machiko Kai, et al.
Cancers
|
April 26, 2025
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 316) with videos related to
Sort By:
Page
of 32
Journal of Gastroenterology
|
May 4, 2011
Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, et al.
The Journal of Dermatology
|
January 25, 2023
Clinical characteristics of patients with psoriasis with family history: A multicenter observational study
Chika Ohata, Hisataka Anezaki, Sakae Kaneko, et al.
Journal of Gastroenterology
|
March 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests
Kazuhito Kawata, Hirokazu Takahashi, Taeang Arai, et al.
Journal of Gastroenterology
|
April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years
Tetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.
Journal of Gastroenterology
|
July 31, 2015
The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin
Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology
|
November 12, 2014
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection
Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology
|
October 26, 2025
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma
Kazuki Maesaka, Hayato Hikita, Yuki Tahata, et al.
Cardiovascular Diabetology
|
December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
Journal of Gastroenterology and Hepatology
|
September 9, 2025
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma
Kazuki Maesaka, Hayato Hikita, Machiko Kai, et al.
Cancers
|
April 26, 2025
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.
Page
of 32